Immunotherapy in Lung Cancer | Corey J Langer, MD

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer — Faculty Presentation 1: Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) – Dr Corey Langer CME information and select publications